ANTI-CXCR3 ANTIBODIES

The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MICHELE YOUD, TIMOTHY D. CONNORS, TRACEY LODIE, RUIYIN CHU, ELIZABETH MASTERJOHN, KAREN B. CARTER, JENNIFER TEDSTONE, JASON ROBERT PINCKNEY
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.